Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Table 3 Details of 53 patients
| Resected tumors(n = 34) | Unresected tumors (n = 19) | Total (n = 53) | GIST (n = 34) | |
| Follow-up period, median (range), mo | 24.9 (6.6-210) | 36.5 (11.2-183.6) | 31.7 (6.6-210) | 27.3 (6.6-210) |
| EUS sessions, median (range) | 3 (2-8) | 4 (2-13) | 3 (2-13) | 3 (2-11) |
| Tumor diameter at initial EUS, median (range), mm | 19.5 (10-30) | 19.0 (11.5-44.8) | 19.1 (10-44.8) | 19.0 (10.9-44.8) |
| Tumor diameter before surgery or FNA, median (range), mm | 28.0 (20-43.1) | 22.8 (15.2-52.1) | 25.3 (13.7-52.1) | 26.7 (13.7-52.1) |
| Time from the final EUS to surgery, median (range) | 3.8 mo (22d-16.3 mo) | - | - | - |
- Citation: Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/10015.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.10015